Assessing Depression in Cardiac Patients: What Measures Should Be Considered?
Author(s) -
Martina Ceccarini,
Gian Mauro Manzoni,
Gianluca Castelnuovo
Publication year - 2014
Publication title -
depression research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 27
eISSN - 2090-133X
pISSN - 2090-1321
DOI - 10.1155/2014/148256
Subject(s) - medicine , depression (economics) , beck depression inventory , mood , psychopathology , cidi , anxiety , psychiatry , patient health questionnaire , hospital anxiety and depression scale , rating scale , mood disorders , clinical psychology , physical therapy , depressive symptoms , anxiety disorder , psychology , economics , macroeconomics , developmental psychology
It is highly recommended to promptly assess depression in heart disease patients as it represents a crucial risk factor which may result in premature deaths following acute cardiac events and a more severe psychopathology, even in cases of subsequent nonfatal cardiac events. Patients and professionals often underestimate or misjudge depressive symptomatology as cardiac symptoms; hence, quick, reliable, and early mood changes assessments are warranted. Failing to detect depressive signals may have detrimental effects on these patients' wellbeing and full recovery. Choosing gold-standard depression investigations in cardiac patients that fit a hospitalised cardiac setting well is fundamental. This paper will examine eight well established tools following Italian and international guidelines on mood disorders diagnosis in cardiac patients: the Hospital Anxiety and Depression Scale (HADS), the Cognitive Behavioural Assessment Hospital Form (CBA-H), the Beck Depression Inventory (BDI), the two and nine-item Patient Health Questionnaire (PHQ-2, PHQ-9), the Depression Interview and Structured Hamilton (DISH), the Hamilton Rating Scale for Depression (HAM-D/HRSD), and the Composite International Diagnostic Interview (CIDI). Though their strengths and weaknesses may appear to be homogeneous, the BDI-II and the PHQ are more efficient towards an early depression assessment within cardiac hospitalised patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom